Phocas Financial Corp’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-214,983
Closed -$2.81M 155
2024
Q4
$2.81M Sell
214,983
-1,981
-0.9% -$26.4K 0.38% 102
2024
Q3
$3.4K Sell
216,964
-144,471
-40% -$2.19M 0.01% 120
2024
Q2
$4.88K Buy
361,435
+208,230
+136% +$4.26M 0.02% 94
2024
Q1
$4.25K Buy
+153,205
New +$3.4M 0.02% 106
2023
Q1
Sell
-178,038
Closed -$3.48M 270
2022
Q4
$3.48M Sell
178,038
-186
-0.1% -$3.63K 0.5% 85
2022
Q3
$4.29M Buy
178,224
+5,823
+3% +$179K 0.67% 69
2022
Q2
$5.42M Buy
172,401
+19,078
+12% +$691K 0.81% 57
2022
Q1
$6.75M Buy
153,323
+34,126
+29% +$1.47M 0.84% 49
2021
Q4
$5.18M Buy
119,197
+34,539
+41% +$1.35M 0.66% 67
2021
Q3
$2.65M Buy
+84,658
New +$3.33M 0.33% 113

Other funds holding ACH

Phocas Financial Corp's ACH Position: Q1 2025 in Review

Phocas Financial Corp sold out of Accendra Health (ACH) in Q1 2025, closing a stake of 214,983 shares — an estimated $2.81M sold.

Phocas Financial Corp first reported a position in ACH in Q3 2021 and held it in 10 quarters. The position peaked at $6.75M in Q1 2022. 242 funds tracked by Wall St. Rank hold ACH as of Q1 2025.

  • Phocas Financial Corp reported no remaining Accendra Health position as of Q1 2025 after selling out during the quarter.
  • Phocas Financial Corp sold 214,983 Accendra Health shares in Q1 2025, an estimated $2.81M.
  • Phocas Financial Corp first reported a position in Accendra Health in Q3 2021 and held it in 10 quarters.
  • Phocas Financial Corp's Accendra Health position peaked at $6.75M in Q1 2022.
  • 242 funds tracked by Wall St. Rank held Accendra Health as of Q1 2025.

Based on Phocas Financial Corp's 13F filing for Q1 2025, filed 9 May 2025.